U.S. federal trademark · Serial No. 77606362
Medical services, namely, providing a comprehensive method of application for the proposed treatment of human spinal cord injuries by utilizing therapeutic bone marrow-derived cells and by autologous transplantation of the cells into the site of spinal cord injury, the spinal canal, and/or intravenously
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.